MSB 1.86% $1.32 mesoblast limited

Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week, page-92

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,386 Posts.
    lightbulb Created with Sketch. 283
    Is the FDA going to delay approval till the beginning of the next US Administration? Then the newly sworn in President can claim all the credit for approval of the first Stem Cell treatment. Maybe all this is part of some back room deal; "you'll get your approval as long as it's a bit delayed".
    There is so much bigger fish to fry than this indication. Has taken so much management attention, it's like we're taking the hardest path to market.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.